Shanghai Titan Scientific Co.Ltd(688133)
The explanation (Revised Version) on the investment of the raised funds in the field of scientific and technological innovation Shanghai Titan Scientific Co.Ltd(688133) (hereinafter referred to as ” Shanghai Titan Scientific Co.Ltd(688133) ” or “the company”) is in accordance with the measures for the administration of securities issuance and registration of companies listed on the science and Innovation Board (for Trial Implementation) and other relevant provisions, in combination with the company’s stock issuance scheme and actual situation to specific objects, This paper studies whether the investment of the funds raised by issuing A-Shares to specific objects in 2021 belongs to the field of scientific and technological innovation, and formulates the description on the investment of the funds raised in this time belongs to the field of scientific and technological innovation (hereinafter referred to as “the description”), the specific contents are as follows: I. The main business of the company
Shanghai Titan Scientific Co.Ltd(688133) by providing scientific research reagents, special chemicals, scientific research instruments and consumables, laboratory construction and scientific research information services, it meets the scientific research related needs of scientific researchers, analysis and testing and quality control personnel. At present, it has become a leading enterprise in China’s scientific service industry.
In order to better meet the differentiated needs of customers, the company promotes the “platform, specialization and personalization” of products and services through independent innovation, R & D and the construction of warehousing and logistics system, and strives to provide high-quality products and professional services for Chinese scientific researchers and quality control personnel. After more than ten years of focused development, the company has successfully built a scientific service platform with international vision, supply chain integration and professional consulting. Since its establishment, the company has served more than 50000 customers, more than 1 million scientists and quality control personnel, served more than 150 of the world’s top 500 enterprises, achieved the full coverage of 985 and 211 Engineering Colleges and universities in China, supported the cutting-edge R & D of many leading enterprises in the fields of biomedicine, new materials, new energy, energy conservation and environmental protection, high-end equipment manufacturing, and contributed to national innovation and upgrading Transformation and development provide a solid and powerful foundation guarantee. 2、 Investment plan of the raised funds
(i) Use plan of raised funds
The total amount of A-Shares issued to specific objects this time does not exceed 1023345900 yuan (including this amount), which are all cash subscriptions. The net amount of the total amount of funds raised this time after deducting the issuance expenses will be used in the following directions:
Unit: 10000 yuan
No. proposed investment of total investment raised funds of the project
No. proposed investment of total investment raised funds of the project
1 Shanghai Titan Scientific Co.Ltd(688133) life science headquarters park project 77434.5977434.59
2 supplementary working capital 24900.0024900.00
Total 102334.59
Within the scope of the above-mentioned projects invested with raised funds, the company can appropriately adjust the investment sequence and specific amount of the corresponding projects invested with raised funds according to the actual situation of the project progress and fund demand. Before the raised funds are in place, the company can invest with self raised funds first according to the actual situation of the projects invested with raised funds, And replace it after the raised funds are in place. After the raised funds are in place, if the actual net amount of raised funds after deducting the issuance expenses is less than the total amount of raised funds to be invested, the insufficient part shall be solved by the company with self raised funds.
（2） Investment projects with raised funds
1. Basic information of the project
(1) Shanghai Titan Scientific Co.Ltd(688133) life science headquarters park project
In order to improve its own scientific research technology level and high-end product manufacturing capacity, and provide more sufficient scientific research materials and professional service support for China’s scientific research industry, the company plans to purchase land in Fengxian comprehensive free trade zone, covering an area of about 91.5 mu, equivalent to 61003.05 square meters, add a new building area of 86589.20 square meters, and introduce advanced equipment and high-quality talent team, Build a comprehensive industrial base integrating R & D, manufacturing, import and export.
The project focuses on the R & D and upgrading of biomedicine, new materials, great health, basic research and other fields, realizes the R & D, production, testing, reserve and import and export integration of biological high-end reagents and high-end instruments, and forms a comprehensive bonded zone life science industrial base focusing on life science and integrating the functions of R & D, manufacturing, import and export and material reserve, Provide customers with self-developed products, third-party high-end products, supporting R & D technology, notification and other services.
The breakdown categories of construction projects are as follows:
S / n item category breakdown category specific platform name
High clean grade laboratory / manufacturing platform for R & D and manufacturing of scientific research reagents
Advanced reaction preparation platform with 1 engine transformation function
R & D and manufacturing platform for R & D and manufacturing of scientific research instruments based on platform precision machining technology
S / n item category breakdown category specific platform name
R & D and manufacturing platform for key core components
Comprehensive technology platform for in vitro functional analysis and detection of scientific research animals
2 scientific research material war–
Strategic reserve base
Advance of scientific research materials
3. Export customs declaration–
platform
The specific construction contents are as follows:
(1) Functional platform for R & D and transformation of scientific services
① Specific contents and results to be achieved
The scientific service R & D transformation functional platform is built around improving the R & D and manufacturing capacity of the company’s independent products. This platform consists of six sub functional platforms: comprehensive platform for precision machining technology, R & D and manufacturing platform for key core components, high-grade laboratory / manufacturing platform, advanced reaction preparation platform, in vitro platform for scientific research animals and comprehensive technology platform for analysis and testing. According to the relationship with the existing product types of the company, the six sub platforms can be divided into three types:
The first category is “R & D and manufacturing of scientific research reagents”, including two sub platforms: high-level clean laboratory / manufacturing platform and advanced reaction preparation platform. The achievements to be realized by such platforms are the R & D and manufacturing of nine products, including: new culture medium series, special serum series, transfection reagent / immunomagnetic beads, biochemical reagent, biological reagent (Kit), biological enzyme / protein / antibody series, deuterated reagent, various standards / high-purity molecules, spectral mass spectrometry and chromatographic reagent. The purpose of this kind of platform is: ① at present, the company has certain competitiveness in high-end chemical reagents, but biological reagents are mainly conventional products. This kind of platform will improve the independent R & D and manufacturing capacity of high-end biological reagents of the company; ② OEM production lacks the stability of supply and cost control of some reagents, and some high-end reagents cannot find OEM manufacturers. The company produces reagents independently through such platforms, which is complementary to the current OEM reagent production.
The second category is “R & D and manufacturing of scientific research instruments”, including two sub platforms: comprehensive platform of precision machining technology and R & D and manufacturing platform of key core components. The achievements to be realized by such platforms are the R & D and manufacturing of eight products and corresponding components, including mass spectrometer, high-performance chromatograph, spectrometer, pretreatment equipment (microwave digestion instrument, etc.), high-end biological instruments (Digital PCR, etc.), high-speed centrifuge, high vacuum diaphragm pump, high-precision thermostatic equipment, etc., as well as their corresponding key components. The purpose of such platform construction is: ① to improve the independent R & D capability of high-end instrument products. Under the background of unstable supply of high-end products in China’s instrument industry and accelerated import substitution process, the company needs to continuously strengthen its own R & D level, carry out R & D of high-end scientific research instruments, master core technology and gradually develop independent and controllable brands; ② Improve the independent production capacity of high-end instrument products. Under the existing OEM production mode, limited by the enterprise scale, most OEM manufacturers lack the production and manufacturing capacity of high-end scientific research instruments and can only realize the OEM production of conventional products. Through the construction of this platform, the company can improve its independent manufacturing capacity and complement the conventional products produced by OEM manufacturers.
The third category is “functional assistance”, including two sub platforms: scientific research animal in vitro platform and analysis and detection comprehensive technology platform. It is a supporting sub platform for scientific research instrument R & D and manufacturing platform and scientific research reagent R & D and manufacturing platform. The achievements of the in vitro platform for scientific research animals are to carry out quality control, application method research and verification of independent brand reagents through the purchase of experimental animal models, and provide customers with supporting reference experimental data for the use of relevant products. The platform is planned to be used internally by the company for the sales of auxiliary products. It does not provide independent external experimental services and does not form direct income. Therefore, no income calculation is carried out. The proposed achievement of the comprehensive technology platform for analysis and detection is to expand the company’s analysis and detection capacity. While supporting the detection needs of self-produced products, it can provide customers with technical services such as comprehensive detection, impurity detection and drug crystal form analysis, so as to form detection service revenue. The main functions and specific contents of each sub platform are as follows:
Platform type platform name main function details
Research, develop and produce high-grade clean biological reagents for independent brands, including special serum, laboratory / manufacturing new culture medium, biological enzymes, research platform for special scientific research reagents, research, development and manufacturing of high-end biological reagents, antibodies, biochemical reagents and other products, and small-scale production and manufacturing.
Advanced reaction preparation aims at the preparation level production of some biological reagents, high-purity trial preparation platform agents and analytical reagents, so as to improve the production capacity of the company’s products.
For the precision processing technology of high-end instruments of independent brands, R & D and manufacturing of precision instruments, R & D and assembly production of complete machines, including instruments and equipment such as mass spectrometer, chromatograph, digital PCR, high-end pre-processing of development and manufacturing.
R & D and manufacturing of core components of precision instruments of the key core department R & D and manufacturing of components of high-end instruments of independent brands are divided into key parts
Platform type platform name main function details
Platform manufacturing, integrated platform with precision machining technology.
Auxiliary platform, mainly through purchase
